Adjuvants used with pandemic influenza vaccines are already licensed for use with other vaccines (e.g. hepatitis B, seasonal or pandemic influenza vaccines, or others), and have a safe track record.
The results showed that the united vaccine of hepatitisa and measles in HAM has no significant difference as compared with single vaccines in the same batch substrate.